Abstract
The mesoporous silica nanoparticles (MSNs), because of the synthesis, ease of surface functionalization, tunable pore size, large surface area, and biocompatibility, are being useful in many of the biomedical applications like drug delivery, theranostics, stem cell research, etc. It has been a potent nanocarrier for many different therapeutic agents, i.e., the surface functionalization of silica nanoparticles (SNs) with chemical agents, polymers, and supramolecular moieties enable the efficient delivery of therapeutic agents in a highly controlled manner. Also, the toxicity, biosafety, and in vivo efficiency involving biodistribution, pharmacokinetics, biodegradation, and excretion of MSNs play an important role in its involvement in the clinical applications. A coherence between chemistry and biological sciences extends its opportunities to a wide range in the field of nanomedicine such as smart drug delivery systems, functionalization and gating approach, controlled drug delivery systems, diagnostic and targeted theragnostic approach etc. Thus, taking advantage of the inbuilt properties of the MSNs applicable to the biomedical sector, the present review describes a panorama on the SNs which are presently used for the development of theragnostic probes and advanced drug delivery platforms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
